A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
暂无分享,去创建一个
L. H. van den Berg | M. Cudkowicz | H. Mitsumoto | A. Ludolph | B. Brooks | M. Bozik | D. Archibald | T. Petzinger | D. Moore | S. Rudnicki | Bing Zhang | J. Mather